Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $16.79

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been given a consensus rating of “Hold” by the nine brokerages that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $16.7857.

MD has been the subject of a number of analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Pediatrix Medical Group in a report on Saturday, September 27th. Zacks Research upgraded shares of Pediatrix Medical Group to a “strong-buy” rating in a research note on Monday, August 11th. Leerink Partners upped their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, UBS Group upped their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research report on Thursday, August 14th.

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $17.52 on Friday. Pediatrix Medical Group has a 12 month low of $11.59 and a 12 month high of $17.77. The company has a market capitalization of $1.53 billion, a P/E ratio of 13.58 and a beta of 1.26. The stock has a 50 day moving average of $15.82 and a two-hundred day moving average of $14.41. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.Pediatrix Medical Group’s revenue was down 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.34 earnings per share. As a group, equities analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently added to or reduced their stakes in MD. Boston Partners increased its holdings in shares of Pediatrix Medical Group by 1.3% during the first quarter. Boston Partners now owns 1,981,889 shares of the company’s stock worth $27,990,000 after buying an additional 25,536 shares in the last quarter. American Century Companies Inc. grew its position in Pediatrix Medical Group by 28.6% during the 2nd quarter. American Century Companies Inc. now owns 1,931,867 shares of the company’s stock worth $27,722,000 after acquiring an additional 430,029 shares during the last quarter. Invesco Ltd. grew its position in Pediatrix Medical Group by 9.3% during the 1st quarter. Invesco Ltd. now owns 863,269 shares of the company’s stock worth $12,509,000 after acquiring an additional 73,157 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Pediatrix Medical Group by 175.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 744,473 shares of the company’s stock valued at $10,683,000 after purchasing an additional 474,186 shares in the last quarter. Finally, Qube Research & Technologies Ltd raised its position in Pediatrix Medical Group by 2.0% in the 2nd quarter. Qube Research & Technologies Ltd now owns 735,526 shares of the company’s stock valued at $10,555,000 after purchasing an additional 14,596 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.